Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT

v3.21.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2018 256,123,515      
Beginning balance, value at Dec. 31, 2018 $ 256,123 $ 111,429,877 $ (113,168,000) $ (1,482,000)
Proceeds from the exercise of options and warrants, shares 11,167,690      
Proceeds from the exercise of options and warrants, value $ 11,168 636,832 648,000
Fair value of common stock issued on conversion of notes payable, shares 42,570,331      
Fair value of common stock issued on conversion of notes payable, value $ 42,570 2,330,430 2,373,000
Fair value of warrants and beneficial conversion feature of issued convertible notes 1,362,000 1,362,000
Fair value of options and warrants issued as compensation 383,000 383,000
Common stock issued for services, shares 250,000      
Common stock issued for services, value $ 250 67,750 68,000
Net loss     (5,621,000) (5,621,000)
Ending balance, shares at Dec. 31, 2019 310,111,536      
Ending balance, value at Dec. 31, 2019 $ 310,111 116,209,889 (118,789,000) (2,269,000)
Proceeds from the exercise of options and warrants, shares 1,215,000      
Proceeds from the exercise of options and warrants, value $ 1,215 59,785 61,000
Fair value of common stock issued on conversion of notes payable, shares 9,854,707      
Fair value of common stock issued on conversion of notes payable, value $ 9,856 400,144 410,000
Fair value of warrants and beneficial conversion feature of issued convertible notes 299,000 299,000
Fair value of options and warrants issued as compensation 377,000 377,000
Common stock issued for services, shares 2,000,000      
Common stock issued for services, value $ 2,000 28,000 30,000
Net loss (2,415,000) (2,415,000)
Ending balance, shares at Dec. 31, 2020 323,181,243      
Ending balance, value at Dec. 31, 2020 $ 323,182 $ 117,373,818 $ (121,204,000) $ (3,507,000)